| EPIC | 4BB |
| Sector | Pharma and Biotech |
| ISIN | GB00BMCLYF79 |
| Market Sector | AIM |
| Market Segment | ASQ1 |
| Main Indices | FTSE AIM All-Share |
| Country of register | Great Britain |
| Currency | British Pound |
| Market Cap | £76.80m |
| NMS | 1,000 |
| Shares in issue | 15.54m |
| Date Listed | n/a |
| Currency | UK Pounds |
| Share Price | 494.29p |
| Change Today | -10.71p |
| % Change | -2.12 % |
| 52 Week High | 1,125.00 |
| 52 Week Low | 474.00 |
| Volume | 4 |
| Shares Issued | 15.54m |
| Market Cap | £76.80m |
| Beta | 0.00 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:12 | 3 @ 530.00p |
| 14:12 | 1 @ 530.00p |
| CFO | David John Roth |
| CEO | Amy Walker |
| COO | Scott Lorimer |
You are here: research